Literature DB >> 21981355

Clinical histories and molecular characterization of two afibrinogenemic patients: insights into clinical management.

E Grandone, G Tiscia, F Cappucci, G Favuzzi, R Santacroce, D Pisanelli, F Soli, C Legnani, M A Rizzo, G Palareti, M Margaglione.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21981355     DOI： 10.1111/j.1365-2516.2011.02656.x

Source DB:  PubMed          Journal:  Haemophilia        ISSN： 1351-8216            Impact factor:   4.287


× No keyword cloud information.
  3 in total

1.  Treating a Patient of Dysfibrinogenemia with Acute Thromboembolism by Rivaroxaban and Cilostazol.

Authors:  Emre Ozker; Figen Atalay; Oyku Gulmez; Bulent Saritas
Journal:  Indian J Hematol Blood Transfus       Date:  2016-11-21       Impact factor: 0.900

2.  Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders.

Authors:  Tomas Simurda; Jana Zolkova; Zuzana Snahnicanova; Dusan Loderer; Ingrid Skornova; Juraj Sokol; Jan Hudecek; Jan Stasko; Zora Lasabova; Peter Kubisz
Journal:  Int J Mol Sci       Date:  2017-12-29       Impact factor: 5.923

Review 3.  Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype.

Authors:  Tomas Simurda; Monika Brunclikova; Rosanna Asselta; Sonia Caccia; Jana Zolkova; Zuzana Kolkova; Dusan Loderer; Ingrid Skornova; Jan Hudecek; Zora Lasabova; Jan Stasko; Peter Kubisz
Journal:  Int J Mol Sci       Date:  2020-06-29       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.